The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Symposium

[S46]New Era in Pharmaco"Epi"genomics -Frontiers in Epigenetics from Basic Science to Drug Discovery-

Sat. Mar 29, 2025 1:30 PM - 3:00 PM JST
Sat. Mar 29, 2025 4:30 AM - 6:00 AM UTC
Room 6 (Fukuoka International Congress Center: 203 [2F])
Organizer: Tomoaki Koga (IMEG, Kumamoto Univ.), Takashi Minami (Div. Mol.Vasc.Biol, IRDA, Kumamoto Univ.), Ito Akihiro (Tokyo Univ. Pharm. Life Sci., Sch. of Life Sci.), Suzuki Takayoshi (SANKEN, Osaka Univ.)
[English Session]
1:30 PM - 1:31 PM JST(4:30 AM - 4:31 AM UTC)

Introduction of “New Era in Pharmaco-Epigenomics ~Frontiers in Epigenetics from Basic Science to Drug Discovery”~：Tomoaki Koga（IMEG, Kumamoto Univ.）

1:31 PM - 1:56 PM JST(4:31 AM - 4:56 AM UTC)

[S46-1]Epigenetic Code in Health and Diseases

○Sung Hee Baek1 (1. Creative Res Initiatives Center for Epigenetic Code and Disease, Dept Biol Sci, Seoul National Univ.)
1:56 PM - 2:11 PM JST(4:56 AM - 5:11 AM UTC)

[S46-2]Epigenetic modifiers in inflammation and fibrosis

○Tomoaki Koga1, Naofumi Funagura1,2, Seonghyeon Hong1, Ayane Noda1, Toshihiro Inoue2, Mitsuyoshi Nakao1 (1. Dept. Med. Cell. Biol., IMEG, Kumamoto Univ., 2. Dept. Ophthalmol, Grad. Sch. Med., Kumamoto Univ.)
2:11 PM - 2:27 PM JST(5:11 AM - 5:27 AM UTC)

[S46-3]VEGF-mediated unique epigenetic modifications defined endothelial cells identification, angiogenesis, and inflammation through our health and disease states

○Takashi Minami1,2 (1. Div. Mol.Vasc.Biol, IRDA, Kumamoto Univ., 2. Div. Mol.Vasc.Biol., Faculty of Life Sci, Kumamoto Univ.)
2:27 PM - 2:43 PM JST(5:27 AM - 5:43 AM UTC)

[S46-4]Development of histone methyltransferase G9a inhibitors for the treatment of sickle cell disease

○Akihiro Ito1 (1. Tokyo Univ. Pharm. Life Sci., Sch. of Life Sci.)
2:43 PM - 2:59 PM JST(5:43 AM - 5:59 AM UTC)

[S46-5]Identification of epigenetic complex disrupters

○Takayoshi Suzuki1 (1. SANKEN, Osaka Univ.)
2:59 PM - 3:00 PM JST(5:59 AM - 6:00 AM UTC)

Future Outlook of “Pharmaco-Epigenomics” and Closing Remarks：Takashi Minami（Div. Mol Vasc Biol, IRDA, Kumamoto Univ.）

Back to Category List